Comparing two surgical approaches for endometrial cancer staging
Part of Cancer, Women’s health & pregnancy clinical trials.
This study compares two minimally invasive surgical techniques for women with early-stage endometrial cancer who need lymph node sampling during their cancer surgery. Both approaches are designed to check if cancer has spread to lymph nodes while causing less trauma to the body than traditional open surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with endometrial cancer (cancer of the uterus lining) confirmed by biopsy
- Your cancer appears to be contained in the uterus only, with no spread to other organs
- Imaging tests (CT, MRI, or PET scan) show no signs of cancer spreading to distant parts of your body
- Your cancer care team has recommended sentinel lymph node biopsy as part of your treatment plan
- You are at least 18 years old
- You have not had prior radiation therapy to your pelvis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two ways to remove lymph nodes during hysterectomy for endometrial cancer that hasn't spread. The goal is to find which method works better with similar or fewer side effects.
This trial compares two ways of removing lymph nodes during a vaginal minimally invasive surgery for early-stage endometrial cancer. It aims to find which method is safer and more effective.
This study compares two ways to check lymph nodes during surgery for early-stage endometrial (uterine) cancer: sentinel node biopsy versus removing more lymph nodes. It may help find whether the less extensive approach can stage the cancer accurately with fewer side effects.
This trial tests whether removing only the first lymph node to detect cancer spread (sentinel node mapping) is as effective as removing all lymph nodes in the pelvic area (comprehensive lymphadenectomy) for a specific type of endometrial cancer with a p53 mutation, stages I–II. The goal is to see if the less extensive surgery can result in similar outcomes while possibly reducing side effects.
This is a research study that looks at outcomes in women with endometrial (uterine) cancer who receive the usual standard surgery. Researchers will group patients based on the final surgical and pathology results and what additional (if any) treatment is recommended afterward.
This trial tests a new way to look at lymph nodes during surgery for gynecologic cancers. It may help doctors decide immediately if cancer has spread to the lymph nodes, which could guide treatment decisions during the same operation.
Hear when a new Endometrial Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.